5 Biological preparations for pharmaceutical purposes for the treatment of pain, itch, diabetes, cancer, and inflammation; pharmaceutical preparations for the treatment of pain, itch, diabetes, cancer, and inflammation; pharmaceutical preparations for animals for the treatment of pain, itch, diabetes, cancer, and inflammation; pharmaceutical preparations for veterinary use for the treatment of pain, itch, diabetes, cancer, and inflammation; radioactive preparations for veterinary use for the treatment of pain, itch, diabetes, cancer, and inflammation; reagents for in-vitro laboratory use for medical diagnostic veterinary purposes; reagents for laboratory purposes for medical diagnostic veterinary purposes; reagents for use in analytical tests for medical diagnostic veterinary purposes; reagents for use in diagnostic tests for medical diagnostic veterinary purposes; reagents for use in the development of monoclonal antibodies for medical diagnostic veterinary purposes; reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) for medical diagnostic veterinary purposes; veterinary preparations for the treatment of pain, itch, diabetes, cancer, and inflammation; veterinary preparations for administration by injection for the treatment of pain, itch, diabetes, cancer, and inflammation; veterinary preparations for immunisation against disease; veterinary preparations for use in improving the skin; veterinary preparations for use in treating the coat; veterinary preparations in dosage forms for veterinary use for the treatment of pain, itch, diabetes, cancer, and inflammation; veterinary products, namely, 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues; veterinary products for equines, namely, fully equinized monoclonal antibodies, equine fusion proteins; veterinary vaccines; biological preparations for veterinary purposes for the treatment of pain, itch, diabetes, cancer, and inflammation; antibodies for pain, itch, diabetes, cancer, and inflammation; immunological antibodies for medical use for the treatment of cancer; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use for pain, itch, diabetes, cancer, and inflammation; monoclonal antibodies for therapeutic purposes for the treatment of pain, itch, diabetes, cancer, and inflammation; products containing antibodies for use in medicine for pain, itch, diabetes, cancer, and inflammation; reagents for use in the development of monoclonal antibodies for medical diagnostic purposes; monoclonal antibodies for medical use for diagnostic purposes for pain, itch, diabetes, cancer and inflammation; biological preparations for medical purposes for the treatment of pain, itch, diabetes, cancer, and inflammation; biological products for medical use, namely, 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues for the treatment of pain, itch, diabetes, cancer, and inflammation; biological reagents for medical diagnostic purposes for use in molecular biology; biological substances for medical use, namely, 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues for the treatment of pain, itch, diabetes, cancer, and inflammation; reagents for use in biological processing for medical diagnostic purposes; reagents for use in biological processing for medical diagnostic purposes for veterinary purposes; therapeutic biological products, namely, 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues for the treatment of pain, itch, diabetes, cancer, and inflammation; monoclonal antibody reagents for medical diagnostic use; medical therapeutic agents for the treatment of pain, itch, diabetes, cancer, and inflammation; medical therapeutic drugs for the treatment of pain, itch, diabetes, cancer, and inflammation; animal care products for veterinary use, namely, 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues or recombinant proteins for the treatment of pain, itch, diabetes, cancer, and inflammation; biotechnological preparations for veterinary use, namely, 100% species-specific monoclonal antibodies, canine or feline fusion proteins, and canine or feline insulin analogues for the treatment of pain, itch, diabetes, cancer, and inflammation
Trademark: 79160219
